Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review

Badran, Mostafa; Abbas, Samar H; Fujita, Mikako; Osman, Mohamed

doi:10.21608/jabps.2023.219233.1191

Derivatives contain dimethylaminopyridine as SIRT2 inhibitors: A mini review

Document Type : Review Articles

Authors

¹ Department of Medicinal Chemistry, Faculty of Pharmacy, South Valley University, Qena, 83523, Egypt

² Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519-Minia, Egypt

³ Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan

⁴ Medicinal Chemistry Department, Faculty of Pharmacy, Minia University.

10.21608/jabps.2023.219233.1191

Abstract

The development of new compounds inhibiting SIRT2, a protein that regulates various biological processes, has attracted significant attention in recent years. This study reported dimethylaminopyridine (DMAP) synthesis and evaluation as a new scaffold for SIRT2 inhibition. DMAP derivatives were designed and synthesized using a combination of computational modeling and synthetic chemistry approaches. A high-throughput screening assay was used to evaluate the ability of compounds to inhibit SIRT2. The most potent compounds were identified and further characterized using cellular and enzymatic assays. This review suggests that DMAP could be a promising scaffold for developing novel SIRT2 inhibitors with potential anticancer activity.

Keywords

Main Subjects